SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,879.96 39.61
(0.37%)

Forex

USD-INR

95.08 -0.14
(-0.15%)

EUR-INR

106.23 -0.27
(-0.26%)

GBP-INR

125.74 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

41.3474594

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

54.69

1681.25

EPS(TTM)

Face Value()

Div & Yield %

7.44

0.12

Back

titan biotech ltd

Titan Biotech consolidated net profit rises 66.17% in the March 2026 quarter

Jun 02,2026

Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	48.83	35.17	39	206.19	156.45	32
OPM %	19.89	12.99	-	18.72	16.25	-
PBDT	11.58	5.87	97	43.10	28.54	51
PBT	10.28	5.03	104	38.17	24.37	57
NP	6.73	4.05	66	29.89	21.53	39

74,729.27 413.66 ( 0.56%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,489.63 1,063.68 (1.65%)

10,879.96 39.61 (0.37%)

95.08 -0.14 (-0.15%)

106.23 -0.27 (-0.26%)

125.74 -0.30 (-0.24%)

0.60 0.00 (-0.23%)